Related
Korro Bio Raises $70 Million to Advance RNA Edited Therapies
Rare Daily Staff Korro Bio, which is developing a new class of genetic medicines based on editing […]
Read moreRNA-Targeted Therapy Shows Promise for a Rare Childhood Dementia
Rare Daily Staff A study in mice suggests a new RNA-targeted therapy can halt the progression of […]
Read moreExpanding Access to Genome Sequencing in Rural Populations
Rare Daily Staff Patients in rural area often face challenges accesses cutting-edge medical technologies, such as state-of-the-art […]
Read moreA Small Molecule Therapy to Regenerate Muscle in People with DMD
Duchenne muscular dystrophy is an inherited disease caused by genetic mutations that no longer allow the dystrophin […]
Read moreArgenx Highlights gMG Drug Data in CIDP
Rare Daily Staff Argenx said that positive data from its phase 3 ADHERE trial evaluating Vyvgart Hytrulo […]
Read moreGroup Calls for Use of Genome Sequencing as First Line Test for Patients Suspected of Genetic Disease
Rare Daily Staff The Medical Genome Initiative, a group made up of sequencing giant Illumina and leading […]
Read moreFDA Grants Fast Track Designation for Lexeo’s Gene Therapy for Friedreich’s Ataxia Cardiomyopathy
Rare Daily Staff The U.S. Food and Drug Administration has granted Fast Track designation to Lexeo Therapeutics’ […]
Read moreAcross Healthcare Enters Collaboration with n-Lorem Foundation to Develop Submission Platform for Docs
Rare Daily Staff The nonprofit foundation n-Lorem has entered into a collaboration with the technology company Across […]
Read moreA 37-Year Path to a Diagnose, but Now a Drug May Be Two Weeks Away
It took Courtney Ampezzan 37 years to get a correct diagnosis for her condition, an unusual length […]
Read more